October 5, 2026

This study explores a novel DNA methylation clock that predicts mortality risk based on immune-metabolic aging signatures, using data from the Framingham Heart Study.

This study explores how blood cell composition influences DNA methylation age and age acceleration, revealing distinct biological interpretations and modest associations with health outcomes.

This study benchmarks proteomic organ clocks against established ageing biomarkers to explore their associations with all-cause mortality in a cohort of older adults.

This study explores how neighborhood amenities, health services, and infrastructure relate to epigenetic aging, suggesting that improved local resources may slow biological aging.

This study explores how blood cell composition affects DNA methylation age and age acceleration, revealing distinct biological interpretations and modest associations with health outcomes.

This study benchmarks plasma proteomic signatures against established ageing biomarkers to explore their association with all-cause mortality in older adults.

This study explores how neighborhood amenities, health services, and infrastructure influence epigenetic aging, suggesting that improved local resources may slow biological aging.

This study explores how blood cell composition influences DNA methylation age and age acceleration, revealing distinct biological interpretations.

This study benchmarks proteomic organ clocks against established ageing biomarkers, revealing associations with all-cause mortality in a cohort of older adults.